Immunotherapies are cancer treatments that help the immune system fight cancer. There are various types of immunotherapies such as immune checkpoint inhibitors, which work by blocking proteins that inhibit the immune response, and T-cell transfer therapy, which involves boosting the activity of T cells to enhance their ability to target cancer cells.

With the identification of blood-borne markers, the RGCC Immune-Frame test pinpoints specific cellular indicators responsible for regulating a patient’s immune system activity. This comprehensive analysis enables clinicians to assess immune function effectively and tailor treatments accordingly for cancer patients. The test pinpoints the specific biological markers to assess the status of the immune system and monitor therapeutic response to cellular therapies.